PFIZER REPORTS THIRD-QUARTER 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Pfizer (PFE) PT Raised to $42 at Credit Suisse
October 31, 2018 8:56 AM EDTCredit Suisse analyst Vamil Divan raised the price target on Pfizer (NYSE: PFE) to $42.00 (from $40.00) while maintaining a Neutral rating.
... MorePfizer (PFE) Tops Q3 EPS by 3c
October 30, 2018 6:47 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.53 billion.
GUIDANCE:
Pfizer sees FY2018 EPS of $2.98-$3.02, versus the consensus of $2.99.Now... More